Medicare (Original + Advantage) denied your gender-affirming care? Here is what to do next
Gender-affirming care denials may implicate the federal Affordable Care Act's Section 1557 anti-discrimination provisions and the WPATH Standards of Care (SOC 8) clinical framework. This guide is specific to Medicare (Original + Advantage) appeals.
If Medicare (Original + Advantage) denied your gender-affirming care, you can appeal, and the plan must give you its file and the criteria it used. Filing windows by plan type: 120 days from the notice (Original Medicare); 65 days from the notice (Medicare Advantage); 65 days from the notice (Part D). The date printed on your denial notice controls; it can only be later than these floors, never earlier.
Why Medicare (Original + Advantage) denies gender-affirming care
Medicare is a federal program with two delivery modes, Original (fee-for-service Part A/B + Part D drug plans) and Advantage (private MA-C plans). Each has its own appeal ladder, and rights are stronger than most beneficiaries realize.
For gender-affirming care specifically: Gender-affirming care denials may implicate the federal Affordable Care Act's Section 1557 anti-discrimination provisions and the WPATH Standards of Care (SOC 8) clinical framework. Coverage rules vary significantly by state and plan type, but appeals grounded in clinical guidelines and federal nondiscrimination law have a strong reversal track record.
ACA § 1557 nondiscrimination protections and the WPATH Standards of Care, Version 8, set the controlling framework.
Note for Medicare (Original + Advantage): where the standard above cites ERISA or the ACA appeal rules, those describe employer and Marketplace plans. The windows and levels that apply to Medicare (Original + Advantage) are in the table below.
Medicare (Original + Advantage) appeals: the rule, the deadline and the next level, by plan type
Original Medicare, Medicare Advantage and Part D each have their own federal ladder. The notice you received says which one you are in.
| Plan type | Rule that governs | File your appeal within | The plan must answer | If the plan says no again |
|---|---|---|---|---|
| Original Medicare (Parts A and B) Fee-for-service Medicare. The Medicare Summary Notice lists the denial. | 42 CFR Part 405, Subpart I. | Redetermination: 120 days from receipt of the initial determination (42 CFR 405.942). Reconsideration by a Qualified Independent Contractor: 180 days from the redetermination (§ 405.962). ALJ hearing: 60 days (§ 405.1002). | The Medicare Administrative Contractor decides a redetermination within 60 days (§ 405.950); the QIC decides within 60 days (§ 405.970). | QIC reconsideration, ALJ hearing (amount-in-controversy threshold), Medicare Appeals Council, federal district court. Fast-track appeals of service terminations go to the Quality Improvement Organization (42 CFR 405.1200 to 405.1206). |
| Medicare Advantage (Part C) A private plan that replaces Original Medicare. The card says Medicare Advantage, HMO, PPO or PFFS. | 42 CFR Part 422, Subpart M (§§ 422.560 to 422.634). Coverage decisions must follow Original Medicare rules (42 CFR 422.101). | 65 calendar days from the date on the denial notice to request the plan's reconsideration (42 CFR 422.582, as amended effective 1 January 2025). | Expedited: 72 hours. Standard pre-service: 30 days (7 days for Part B drugs). Payment: 60 days (42 CFR 422.590). | If the plan does not fully reverse itself it must send the case to the Independent Review Entity on its own (42 CFR 422.592); then an ALJ hearing when the amount in controversy meets the annual threshold, the Medicare Appeals Council and federal court. State external review does not apply. |
| Medicare Part D (drug plan or MA-PD) A stand-alone drug plan or the drug benefit inside a Medicare Advantage plan. | 42 CFR Part 423, Subpart M; exceptions under 42 CFR 423.578. | 65 calendar days from the date on the notice to request a redetermination (42 CFR 423.582, as amended effective 1 January 2025). Formulary, tiering and step-therapy exceptions need the prescriber's supporting statement (§ 423.578). | Redetermination: 7 calendar days standard, 72 hours expedited (42 CFR 423.590). Coverage determinations: 72 hours standard, 24 hours expedited, once the prescriber's statement is received (§§ 423.568, 423.572). | Independent Review Entity reconsideration on your request within 65 days of the redetermination notice (§ 423.600); then ALJ, Council and court. |
What you can demand. Follow the appeal instructions on the Medicare Summary Notice or use form CMS-20027. Your provider can appeal for you; any other representative needs form CMS-1696.
How to open the appeal. Cite 42 CFR 405.942 and the coverage rule that applies (the national or local coverage determination), and attach the treating clinician's statement addressed to each coverage criterion.
What you can demand. The plan may not apply internal criteria that are more restrictive than Medicare's national and local coverage determinations, and must decide medical necessity on your individual circumstances (42 CFR 422.101(b), (c)). You can ask for the case file and the criteria used.
How to open the appeal. Cite 42 CFR 422.582 and 422.101(c): the plan must decide on your individual circumstances under Medicare coverage rules, and must forward an unfavorable reconsideration to the IRE itself.
What you can demand. The exception turns on the prescriber's statement that the formulary alternative would be less effective or would harm you (42 CFR 423.578(b)(5)).
How to open the appeal. Cite 42 CFR 423.578 and 423.582 and attach the prescriber's supporting statement written to the exception standard.
Primary sources for this table
- 42 CFR Part 405, Subpart I, Original Medicare appeals
- Medicare.gov, claims and appeals
- 42 CFR Part 422, Subpart M, Medicare Advantage grievances, organization determinations and appeals
- 42 CFR 422.101, Medicare Advantage coverage rules and medical-necessity decisions
- 42 CFR Part 423, Subpart M, Part D coverage determinations, redeterminations and reconsiderations
- 42 CFR 423.578, Part D exceptions process
Windows are federal floors or the rule as written; the denial notice controls. Reviewed 13 September 2026. General information, not legal advice; Apellica is not a law firm.
What Medicare (Original + Advantage) denies for gender-affirming care
The gender-affirming care services most often denied:
- Hormone therapy (estrogen, testosterone, GnRH agonists)
- Gender-affirming surgery (chest, genital, facial)
- Mental health support related to gender dysphoria
- Fertility preservation prior to hormone therapy
- Voice therapy and electrolysis
Why gender-affirming care claims get denied
A typical Medicare (Original + Advantage) gender-affirming care denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:
- Plan has a categorical exclusion for 'transgender services'
- Plan claims procedure is cosmetic
- Plan does not list the CPT code as covered
- Documentation of gender dysphoria diagnosis incomplete
- Plan applies medical-necessity criteria inconsistent with WPATH SOC 8
The Medicare (Original + Advantage) appeal process
Appeal levels: 5 federal levels. Each has its own deadline; the ALJ and court levels require the amount in controversy to meet the annual threshold CMS publishes.
Carrier timing: 120 days from the notice for level 1 in Original Medicare (redetermination) or 65 days for Medicare Advantage reconsideration (42 CFR 422.582). Later levels: 180 days for the QIC reconsideration in Original Medicare, then 60 days each.
Gender-affirming timing for Medicare (Original + Advantage): the filing windows and decision clocks in the table above apply; the date on the notice controls.
What we know about Medicare (Original + Advantage): Medicare cases require a CMS-1696 Appointment of Representative form for us to act on your behalf. We provide this at intake.
Common Medicare (Original + Advantage) denial patterns for gender-affirming care
- Original Medicare: 5-level appeal. Redetermination by MAC → reconsideration by QIC → ALJ hearing → Medicare Appeals Council → federal district court. The QIC and ALJ levels reverse a substantial share of denials when properly briefed.
- Medicare Advantage: identical 5-level ladder. MA plans must follow the same federal appeal structure as Original Medicare. Plan-level reconsideration → Independent Review Entity (Maximus) → ALJ → Council → federal court.
- Part D drug coverage denials. Part D appeals follow a separate but parallel ladder. Tiering exceptions and formulary exceptions are filed before a coverage determination challenge.
How to win your Medicare (Original + Advantage) gender-affirming care appeal
Strategy for gender-affirming care: Cite WPATH Standards of Care, Version 8 for clinical medical-necessity standards. For ACA-regulated plans, cite Section 1557 anti-discrimination protections, categorical transgender exclusions have been ruled discriminatory in multiple federal courts. State Medicaid programs in many states are required to cover medically necessary gender-affirming care. Include the diagnosing clinician's letter establishing gender dysphoria and the treating clinician's medical-necessity rationale.
Filed against Medicare (Original + Advantage), that strategy rides on this procedural spine:
- Procedural-rights anchor. Cite 42 CFR 405.942 and the coverage rule that applies (the national or local coverage determination), and attach the treating clinician's statement addressed to each coverage criterion. If your Medicare (Original + Advantage) coverage is a different plan type (Medicare Advantage, Medicare Part D), use that row of the table above instead; the rule and the deadline change with the plan, not the carrier.
- Criteria-disclosure demand. Medicare (Original + Advantage) frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
- Controlling-standard citation. ACA § 1557 nondiscrimination protections and the WPATH Standards of Care, Version 8, set the controlling framework.
- Treating-provider attestation. A letter from the treating physician addressing each criterion in Medicare (Original + Advantage)'s own policy language. This is the single strongest evidentiary element.
- Requested action. A specific demand to reverse the gender-affirming care denial and approve the service, not a general "please reconsider."
Documents you'll need for your Medicare (Original + Advantage) gender-affirming care appeal
- Denial letter and plan exclusion language
- Diagnosing mental health clinician's letter (gender dysphoria diagnosis)
- Treating surgeon's / endocrinologist's letter of medical necessity
- WPATH SOC 8 citation aligned with proposed care
- Documentation of any prior care (hormones, mental health support)
What a gender-affirming care appeal can recover
Typical recovery for gender-affirming care cases runs $2,000 - $100,000+ depending on procedure. The exact figure depends on the specific service and your plan's contracted rates.
Medicare (Original + Advantage) gender-affirming care appeals: frequently asked questions
Can I appeal your Medicare (Original + Advantage) gender-affirming care denial?
Yes. Denials may implicate the Affordable Care Act's Section 1557 nondiscrimination protections and the WPATH Standards of Care, Version 8. Appeals grounded in clinical guidelines and federal nondiscrimination law have a strong reversal record.
Are categorical 'transgender services' exclusions legal?
They are vulnerable. Categorical exclusions of gender-affirming care have been ruled discriminatory in multiple federal courts under ACA Section 1557, which is a direct basis to challenge a blanket exclusion by Medicare (Original + Advantage).
What clinical standard should I cite?
The WPATH Standards of Care, Version 8, for medical necessity, paired with the diagnosing clinician's letter establishing gender dysphoria and the treating clinician's rationale aligned to that standard.
Where else can I file besides the plan appeal?
Section 1557 complaints can be filed with the HHS Office for Civil Rights, and many state Medicaid programs are required to cover medically necessary gender-affirming care.
What Apellica does for Medicare (Original + Advantage) gender-affirming care appeals
We file appeals against Medicare (Original + Advantage) specifically configured to its internal review process. Every gender-affirming care appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.
Cost: $0 upfront. We work on contingency for Medicare (Original + Advantage) appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.
Start your Medicare (Original + Advantage) gender-affirming care appeal
Submit a 2-minute intake. A senior reviewer responds within one business day with the specific appeal strategy for your case.
Start free appeal review →Questions people ask next
- External review of an insurance denial: how does it work?
- Do I need a lawyer to appeal a health insurance denial?
- Who can help me appeal a denied health insurance claim?
What to read next
- Medical Necessity Denial: How to Appeal It — the full guide to this kind of denial, for any insurer
- Gender-affirming care appeal letter template — free, fill in your own details
- How gender-affirming care denials are appealed
- Work out your own appeal deadline
Related Medicare (Original + Advantage) guides
- Medicare (Original + Advantage) surgery denials appeal guide
- Medicare (Original + Advantage) mri and imaging denials appeal guide
- Medicare (Original + Advantage) medication and prescription denials appeal guide
- Medicare (Original + Advantage) prior authorization denials appeal guide